FDA Approves New Products

January 23, 2019
American Veterinarian Staff

American Veterinarian, January 2019, Volume 4, Issue 1

The FDA has approved two new products, one for feline parasite protection and the other for canine noise aversion.

REVOLUTION PLUS (SELAMECTIN AND SAROLANER TOPICAL SOLUTION; ZOETIS)

The 6-in-1 feline parasite preventive protects against fleas (Ctenocephalides felis), ticks (black-legged or deer ticks [Ixodes scapularis], Gulf Coast ticks [Amblyomma maculatum], and American dog ticks [Dermacentor vari­abilis]), ear mites (Otodectes cynotis), roundworms (Toxocara cati), hookworms (Ancylostoma tubaeforme), and heartworms (Dirofilaria immitis). The product can be used in cats and kittens as young as 8 weeks that weigh at least 2.8 lb.

PEXION (IMEPITOIN TABLETS; BOEHRINGER INGELHEIM)

Approved for the treatment of noise aversion in dogs, Pexion is dosed (according to weight) twice daily starting 2 days before an expected noise event and continued through the day of the event. The medication will be provided in 100- and 400-mg scored tablets. Due to “capacity constraints at the manufacturing site," however, Pexion will likely not be available for sale until 2020, according to a Boehringer-Ingelheim spokesperson.

download issueDownload Issue : January 2019